McKesson Corporation (MCK) - Total Liabilities
Based on the latest financial reports, McKesson Corporation (MCK) has total liabilities worth $83.16 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
McKesson Corporation - Total Liabilities Trend (1995–2026)
This chart illustrates how McKesson Corporation's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of McKesson Corporation to evaluate short-term liquidity relative to the company's equity base.
McKesson Corporation Competitors by Total Liabilities
The table below lists competitors of McKesson Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Glencore plc
MX:GLENN
|
Mexico | MX$108.59 Billion |
|
Blackstone Group Inc
NYSE:BX
|
USA | $26.91 Billion |
|
CHRISTIAN DIOR ADR1/4/EO2
F:DIO0
|
Germany | €72.69 Billion |
|
Compagnie Financière Richemont SA
SW:CFR
|
Switzerland | CHF19.19 Billion |
|
Barclays PLC
MX:BCSN
|
Mexico | MX$1.62 Trillion |
|
Vertiv Holdings Co
NYSE:VRT
|
USA | $8.27 Billion |
|
SK Square Co Ltd
KO:402340
|
Korea | ₩2.39 Trillion |
|
The Bank of New York Mellon Corporation
NYSE:BK
|
USA | $516.20 Billion |
Liability Composition Analysis (1995–2026)
This chart breaks down McKesson Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MCK stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -38.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how McKesson Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for McKesson Corporation (1995–2026)
The table below shows the annual total liabilities of McKesson Corporation from 1995 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | $83.16 Billion | +8.23% |
| 2025-03-31 | $76.83 Billion | +11.29% |
| 2024-03-31 | $69.04 Billion | +8.20% |
| 2023-03-31 | $63.81 Billion | -1.97% |
| 2022-03-31 | $65.09 Billion | +2.39% |
| 2021-03-31 | $63.57 Billion | +16.56% |
| 2020-03-31 | $54.54 Billion | +9.09% |
| 2019-03-31 | $49.99 Billion | +2.31% |
| 2018-03-31 | $48.87 Billion | +1.03% |
| 2017-03-31 | $48.37 Billion | +4.81% |
| 2016-03-31 | $46.15 Billion | +3.94% |
| 2015-03-31 | $44.40 Billion | +7.14% |
| 2014-03-31 | $41.44 Billion | +49.52% |
| 2013-03-31 | $27.72 Billion | +5.54% |
| 2012-03-31 | $26.26 Billion | +10.97% |
| 2011-03-31 | $23.67 Billion | +14.57% |
| 2010-03-31 | $20.66 Billion | +8.30% |
| 2009-03-31 | $19.07 Billion | +3.20% |
| 2008-03-31 | $18.48 Billion | +4.60% |
| 2007-03-31 | $17.67 Billion | +17.27% |
| 2006-03-31 | $15.07 Billion | +11.62% |
| 2005-03-31 | $13.50 Billion | +21.90% |
| 2004-03-31 | $11.07 Billion | +15.02% |
| 2003-03-31 | $9.63 Billion | +4.80% |
| 2002-03-31 | $9.19 Billion | +17.17% |
| 2001-03-31 | $7.84 Billion | +18.60% |
| 2000-03-31 | $6.61 Billion | +10.11% |
| 1999-03-31 | $6.00 Billion | +49.91% |
| 1998-03-31 | $4.01 Billion | +7.75% |
| 1997-03-31 | $3.72 Billion | +56.05% |
| 1996-03-31 | $2.38 Billion | -0.99% |
| 1995-03-31 | $2.41 Billion | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; d… Read more